High Growth Tech And 2 Other Promising Stocks For Your Portfolio [Yahoo! Finance]
TG Therapeutics, Inc. (TGTX)
Last tg therapeutics, inc. earnings: 11/12 07:34 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.tgtherapeutics.com
Company Research
Source: Yahoo! Finance
As investors navigate this dynamic landscape, identifying high-growth opportunities in the tech sector and other promising areas can be crucial for portfolio diversification and potential long-term gains. Name Revenue Growth Earnings Growth Growth Rating Material Group ?????? Yggdrazil Group ?????? eWeLLLtd ?????? Medley ?????? TG Therapeutics ?????? Seojin SystemLtd ?????? Alkami Technology ?????? Mental Health TechnologiesLtd ?????? Travere Therapeutics ?????? UTI ?????? Click here to see the full list of 1288 stocks from our High Growth Tech and AI Stocks screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Growth Rating: ?????? Overview: Jiangsu Etern Company Limited operates in the communication cable industry with a market capitalization of CN¥7.10 billion. Operations: Etern's business involves the production and sale of communication cables. The company generates revenue prima
Show less
Read more
Impact Snapshot
Event Time:
TGTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TGTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TGTX alerts
High impacting TG Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TGTX
News
- TG Therapeutics, Inc. (NASDAQ: TGTX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
- TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.MarketBeat
- TG Therapeutics says 2024 Briumvi sales topped expectations [Seeking Alpha]Seeking Alpha
- TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones [Yahoo! Finance]Yahoo! Finance
- TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development MilestonesGlobeNewswire
TGTX
Earnings
- 11/4/24 - Miss
TGTX
Sec Filings
- 1/30/25 - Form 4
- 1/30/25 - Form 4
- 1/14/25 - Form 8-K
- TGTX's page on the SEC website